Overall, the index has still been in the range with 19,750-19,800 likely to act as a crucial resistance as breaking of the same can drive the Nifty50 towards 20,000 mark, whereas 19,500 is expected to be immediate support and 19,200 may be crucial support for the index, experts said
Saurabh Mukherjea of Marcellus Investment Managers has also been consistently adding the stock in his Little Champs Portfolio, which focuses on investing in quality midcap and small-cap companies for a long term.
YES Securities is bullish on Metropolis Healthcare has recommended buy rating on the stock with a target price of Rs 1520 in its research report dated May 17, 2023.
YES Securities is bullish on Metropolis Healthcare has recommended buy rating on the stock with a target price of Rs 1720 in its research report dated February 14, 2023.